The Claim

In adults with obesity and type 2 diabetes, weekly intravenous administration of bimagrumab at 10 mg/kg for 48 weeks reduces total body fat mass by approximately 22.2% and increases total body lean mass by 3.6%, despite no significant change in daily caloric intake, indicating a direct pharmacological effect on body composition independent of appetite suppression.

Source: 370-OR: Optimized Weight Loss with Bimagrumab—Reduced Fat Mass with Increased Muscle Mass by Appetite-Independent Mechanisms

What the research says

Supports is higher

Support is ahead, but a single strong opposing study can change this.

Supports
70score
Challenges
0score

These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.

Cause and effect
1 study reviewed
In plain English

In adults with obesity and type 2 diabetes, receiving bimagrumab via intravenous injection once a week for 48 weeks reduces body fat by 22.2% and increases lean mass by 3.6%, without changes in calorie intake, showing the drug directly alters body composition.

See the scientific wording

In adults with obesity and type 2 diabetes, weekly intravenous administration of bimagrumab at 10 mg/kg for 48 weeks reduces total body fat mass by approximately 22.2% and increases total body lean mass by 3.6%, despite no significant change in daily caloric intake, suggesting a direct pharmacological effect on body composition independent of appetite suppression.

Why this might work

Bimagrumab binds to specific receptors on muscle and fat cells, blocking signals that normally limit muscle growth and promote fat storage. This allows muscle cells to build more protein and grow larger, while fat cells stop storing fat and break down existing fat deposits, leading to more muscle and less fat without changing food intake.

Verified mechanismbased on 1 study

What the research says

1 study

  1. Study: 370-OR: Optimized Weight Loss with Bimagrumab—Reduced Fat Mass with Increased Muscle Mass by Appetite-Independent Mechanisms

    This drug, bimagrumab, helped people with obesity and diabetes lose fat and gain muscle without making them eat less — meaning it directly changed how their bodies stored fat and built muscle, like a targeted reset button for body composition.

Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.